MAIA Biotechnology, Inc. (MAIA) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 49.14M |
| Enterprise Value | -8.61B |
| P/E Ratio | -2.29 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.61 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.14 |
| Return On Equity | -1.53 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -22.4M |
| Net Income | -22.4M |
| Diluted EPS | -0.7 |
| Total Cash | 21.34M |
| Total Cash/Share | 0.35 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.41 |
| Book Value Per Share | 0.24 |
| 52-Week Change | 12.23 |
| 52-Week High | 3.19 |
| 52-Week Low | 0.89 |
| Moving Average 50 Days | 1.17 |
| Moving Average 200 Days | 1.37 |
| Average Volume | 524,293 |
| Shares Outstanding | 61.75M |
| % Held by Institutions | 19.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |